Neuromyopathy with congenital cataracts and glaucoma: a distinct syndrome caused by POLG variants

[1]  N. Osborne,et al.  Visual light effects on mitochondria: The potential implications in relation to glaucoma. , 2017, Mitochondrion.

[2]  F. Santorelli,et al.  Concentric muscle involvement in POLG-related distal myopathy , 2017, Neuromuscular Disorders.

[3]  K. DeBalsi,et al.  Synergistic Effects of the in cis T251I and P587L Mitochondrial DNA Polymerase γ Disease Mutations* , 2017, The Journal of Biological Chemistry.

[4]  B. Udd,et al.  Targeted next-generation sequencing assay for detection of mutations in primary myopathies , 2016, Neuromuscular Disorders.

[5]  R. Gallego-Pinazo,et al.  Oxidative stress and mitochondrial failure in the pathogenesis of glaucoma neurodegeneration. , 2015, Progress in brain research.

[6]  P. Chinnery,et al.  POLG-Related Disorders , 2014 .

[7]  P. Seeman,et al.  Congenital cataract, facial dysmorphism and demyelinating neuropathy (CCFDN) in 10 Czech gypsy children – frequent and underestimated cause of disability among Czech gypsies , 2014, Orphanet Journal of Rare Diseases.

[8]  J. Vallat,et al.  Autosomal recessive Charcot‐Marie‐Tooth disease: from genes to phenotypes , 2013, Journal of the peripheral nervous system : JPNS.

[9]  J. Holton,et al.  Distal myopathy with cachexia: an unrecognised phenotype caused by dominantly-inherited mitochondrial polymerase γ mutations , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[10]  E. Ricci,et al.  New phenotype and pathology features in MYH7-related distal myopathy , 2012, Neuromuscular Disorders.

[11]  A. Willis,et al.  POLG mutation in a patient with cataracts, early-onset distal muscle weakness and atrophy, ovarian dysgenesis and 3-methylglutaconic aciduria. , 2012, Gene.

[12]  A. Willis,et al.  POLG Mutation in a Patient with Cataracts, Early-Onset Distal Muscle Weakness and Atrophy and Ovarian Dysgenesis (P07.207) , 2012 .

[13]  E. Ricci,et al.  Muscle imaging findings in GNE myopathy , 2012, Journal of Neurology.

[14]  W. Craigen,et al.  Mitochondrial DNA polymerase γ mutations: an ever expanding molecular and clinical spectrum , 2011, Journal of Medical Genetics.

[15]  F. Santorelli,et al.  Relative frequency of known causes of multiple mtDNA deletions: Two novel POLG mutations , 2011, Neuromuscular Disorders.

[16]  S. Saitoh,et al.  Genetic analysis of two Japanese families with progressive external ophthalmoplegia and parkinsonism , 2011, Journal of Neurology.

[17]  Robert W. Taylor,et al.  Isolated distal myopathy of the upper limbs associated with mitochondrial DNA depletion and polymerase gamma mutations. , 2010, Archives of neurology.

[18]  M. Milone,et al.  Polymerase Gamma 1 Mutations: Clinical Correlations , 2010, The neurologist.

[19]  F. Muntoni,et al.  Centronuclear myopathy with cataracts due to a novel dynamin 2 (DNM2) mutation , 2010, Neuromuscular Disorders.

[20]  H. Smeets,et al.  The unfolding clinical spectrum of POLG mutations , 2009, Journal of Medical Genetics.

[21]  J. Ganesh,et al.  Molecular and clinical genetics of mitochondrial diseases due to POLG mutations , 2008, Human mutation.

[22]  Robert W. Taylor,et al.  Phenotypic spectrum associated with mutations of the mitochondrial polymerase γ gene. Commentary , 2006 .

[23]  Robert W. Taylor,et al.  Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. , 2006, Brain : a journal of neurology.

[24]  S. Dimauro,et al.  A Novel Polymerase γ Mutation in a Family With Ophthalmoplegia, Neuropathy, and Parkinsonism , 2004 .

[25]  S. Dimauro,et al.  A novel polymerase gamma mutation in a family with ophthalmoplegia, neuropathy, and Parkinsonism. , 2004, Archives of neurology.